<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00299624</url>
  </required_header>
  <id_info>
    <org_study_id>TAPH</org_study_id>
    <nct_id>NCT00299624</nct_id>
  </id_info>
  <brief_title>Effect of Aging on Haemostasis Parameters</brief_title>
  <official_title>Identifying Morphological and Biological Biomarkers of the Venous Thromboembolic Risk Risk Related to Aging</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hopital Lariboisière</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hopital Lariboisière</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Aging is an independent risk factor, without any clear explanation. The primary aim of the
      study is to depict the effect of aging on the coagulation fibrinolysis parameters and
      microparticles.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients older than 40, without any acute disease and not receiving any antiaggregant and
      anticoagulant therapy will be included in the study. Blood tests will be performed for
      coagulation, fibrinolysis and microparticles measurement.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2005</start_date>
  <completion_date type="Actual">August 2006</completion_date>
  <primary_completion_date type="Actual">August 2006</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Aging</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Stable patients without overt acute clinical event, not receiving antiplatelet or
        anticoagulant treatment
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age &lt;40 2 groups : 1 : no history of VTE 2 : history of VTE

        Exclusion Criteria:

          -  antiaggregant or anticoagulant therapy at curative dose

          -  arterial or thrombotic event in the last month
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>isabelle mahé, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>MCU-PH</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital Lariboisiere</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hopital Lariboisière</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>September 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 6, 2006</study_first_submitted>
  <study_first_submitted_qc>March 6, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2006</study_first_posted>
  <last_update_submitted>September 13, 2010</last_update_submitted>
  <last_update_submitted_qc>September 13, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 14, 2010</last_update_posted>
  <responsible_party>
    <name_title>Pr Isabelle MAHE</name_title>
    <organization>Hopital Lariboisière</organization>
  </responsible_party>
  <keyword>venous thromboembolism risk,</keyword>
  <keyword>elderly,</keyword>
  <keyword>hypercoagulability</keyword>
  <keyword>fibrinolysis</keyword>
  <keyword>microparticles</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

